Literature DB >> 21918656

The swinging thyroid in hepatitis C infection and interferon therapy.

Huy A Tran1.   

Abstract

Described is a case of triphasic thyroid response in a 53-year-old man while undergoing combination interferon α-2b and ribavirin treatment for chronic hepatitis C infection. He developed the classical biphasic thyroiditis during treatment and was treated expectantly. However, 8 weeks after the completion of therapy, he developed T3-Graves-like thyrotoxicosis, which was confirmed with a diffuse-uptake thyroid scan and positive thyroid stimulating immunoglobulin. He was treated as having Graves' disease arising de novo with thiourea, and he achieved rapid remission. This is thought to be only the second case described, and it offers a unique opportunity to understand the possible pathogenesis of this fascinating condition. This is a relative novel entity and highlights the need for continuing thyroid monitor after treatment. Management also needs to be specific for each particular phase of the condition.

Entities:  

Year:  2009        PMID: 21918656      PMCID: PMC3029615          DOI: 10.1136/bcr.07.2008.0464

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

Review 1.  Graves' disease.

Authors:  A P Weetman
Journal:  N Engl J Med       Date:  2000-10-26       Impact factor: 91.245

Review 2.  Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects.

Authors:  C Carella; G Mazziotti; G Amato; L E Braverman; E Roti
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

3.  American Gastroenterological Association medical position statement on the management of hepatitis C.

Authors:  Jules L Dienstag; J G McHutchison
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

4.  Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease.

Authors:  Nathalie Lévy Bohbot; Jacques Young; Jacques Orgiazzi; Catherine Buffet; Maud François; Brigitte Bernard-Chabert; Céline Lukas-Croisier; Brigitte Delemer
Journal:  Eur J Endocrinol       Date:  2006-03       Impact factor: 6.664

Review 5.  Biochemical mechanisms of thyroid hormone deiodination.

Authors:  George G J M Kuiper; Monique H A Kester; Robin P Peeters; Theo J Visser
Journal:  Thyroid       Date:  2005-08       Impact factor: 6.568

6.  Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C?

Authors:  Roberta Minelli; Maria Antonietta Valli; Clelia Di Seclì; Lorenzo Finardi; Paolo Chiodera; Roberto Bertoni; Carlo Ferrari; Angela Luciana Barilli; Vittorio Coiro; Gloria Saccani Jotti; Roberto Delsignore
Journal:  Horm Res       Date:  2005-04-28

Review 7.  Treating viral hepatitis C: efficacy, side effects, and complications.

Authors:  M P Manns; H Wedemeyer; M Cornberg
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

Review 8.  Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection.

Authors:  Andrew R Lloyd; Emma Jagger; Jeffrey J Post; Lee-Ann Crooks; William D Rawlinson; Young S Hahn; Rosemary A Ffrench
Journal:  Immunol Cell Biol       Date:  2006-11-28       Impact factor: 5.126

9.  Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis.

Authors:  Vincent Wong; Angela Xi-Li Fu; Jacob George; N Wah Cheung
Journal:  Clin Endocrinol (Oxf)       Date:  2002-06       Impact factor: 3.478

Review 10.  NIH Consensus Statement on Management of Hepatitis C: 2002.

Authors: 
Journal:  NIH Consens State Sci Statements       Date:  2002 Jun 10-12
View more
  1 in total

1.  Hashimoto's Thyroiditis and Graves' Disease in One Patient: The Extremes of Thyroid Dysfunction Associated with Interferon Treatment.

Authors:  R H Bishay; R C Y Chen
Journal:  Case Rep Endocrinol       Date:  2016-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.